Genes responsible for Charcot-Marie-Tooth (CMT), a usual hereditary neurological disorder affecting the peripheral nerves of infector's limbs, have been identified jointly by Dr James Lupski of Molecular and Human Genetics at BCM Texas along with Dr Richard Gibbs, Director of the Human Genome Sequencing Center at BCM, where the experimental sequencing took place. This was concluded by experimenting with genetic sequences in order to detect contributory mutation by genes associated that lead to this "inherited neurological disorder".

Dr. Lupski himself is infected since 40 years from "genetically-recessive disease". Detailed analysis of the study was brought up by 10 March online issue of "New England Journal of Medicine".

CMT is found in one out of 2500 people in US, reported National Institute of Neurological Disorders and Stroke. CMT is also called Hereditary Motor and Sensory Neuropathy (HMSN) or Peroneal Muscular Atrophy in medical terms.

Dr. Lupski said that the discussions regarding the mutation of genes demonstrate that the technology is forceful and that it can be used now. The initiation, according to him will make it possible to interpret the clinical information according to the sequence being dealt.

President of Genomic analysis for Life Technologies Shaf Yousaf said that a wonderful opportunity prevails in order to apply the proof-of-principle and quickly move ahead for discovery of other rare genetic mutations related to the disease.